Kontakt 2024, 26(2):133-137 | DOI: 10.32725/kont.2024.020

Quality of life in patients with migraineNursing - Original article

Michaela Miertová1, *, Katarína Jankovská2, Anna Ovšonková1, Anna Barnau3
1 Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Department of Nursing, Martin, Slovak Republic
2 Faculty Hospital with Polyclinic, Department of Anesthesiology and Intensive Medicine, Žilina, Slovak Republic
3 Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Department of Foreign Languages, Martin, Slovak Republic

Aim: To assess the quality of life in adult patients with migraine.

Methods: The sample consisted of 194 respondents. The Migraine Specific Quality of Life Questionnaire (MSQ version 2.1) was used for data collection. Data were evaluated using descriptive statistics and correlation analysis.

Results: The sample consisted of 92.3% women and 7.7% men with a mean age of 42.085 ± 10.48 years. The median duration of migraine was 15.70 ± 10.64 years. The majority were those with secondary education (56.2%) and those doing mental work (60.8%). According to the average score achieved in the MSQ version 2.1, patients' quality of life was at average level (M = 50.1). Our results showed that, longer duration (p = 0.012), and high frequency of migraine attacks per month (p < 0.001) and per year (p < 0.001) reduced the quality of life. Meanwhile, the quality of life increased with increasing education. Finally, sex (p = 0.466), occupation (p = 0.079) and migraine medication use (p = 0.052) did not prove to be significant variables in relation to the quality of life.

Conclusion: Understanding the quality of life of adult patients with migraine using the MSQ version 2.1 is important for the effective management of this disease. Nurses and physicians should routinely evaluate the quality of life of patients with severe chronic neurological disease as a complementary assessment of patients with migraine.

Keywords: Migraine; Migraine Specific Quality of Life Questionnaire; Patient; Quality of life (MSQ version 2.1)
Conflicts of interest:

The authors have no conflict of interest to declare.

Received: December 7, 2023; Revised: March 26, 2024; Accepted: April 29, 2024; Prepublished online: April 29, 2024; Published: May 31, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Miertová M, Jankovská K, Ovšonková A, Barnau A. Quality of life in patients with migraine. Kontakt. 2024;26(2):133-137. doi: 10.32725/kont.2024.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Agoklu H (2018). User's guide to correlation coefficients. Turk J Emerd Med 18(3): 91-93. DOI: 10.1016/j.tjem.2018.08.001. Go to original source... Go to PubMed...
    2. Al Ghadeer HA, AlSalman SA, Albaqshi FM, Alsuliman SR, Alsowailem FA, Albusror HA, et al. (2021). Quality of life and disability among migraine patients: A single-center study in AlAhsa, Saudi Arabia. Cureus 13(11): e19210. DOI: 10.7759/cureus.19210. Go to original source... Go to PubMed...
    3. AlHarbi FG, AlAteeq MA (2020). Quality of life of migraine patients followed in neurology clinics in Riyadh, Saudi Arabia. J Family Community Med 27(1): 37-45. DOI: 10.4103/jfcm.JFCM_185_19. Go to original source... Go to PubMed...
    4. Alkahtani RF, Alrumaih SS, Algezlan SS, Almutairi RR, Alturki BA, Alanazi RM, et al. (2022). The impact of migraine disease on work productivity and quality of life among the adults in Riyadh, Saudi Arabia. Cureus 14(8): e27733. DOI: 10.7759/cureus.27733. Go to original source... Go to PubMed...
    5. Almosaiteer SA, Rabbani U, Alharbi BA, Aldukhayel A (2022). Quality of life and its predictors among patients with migraine in Qassim region, Saudi Arabia: a cross-sectional study. Egypt J Neurol Psychiatry Neurosurg 58: 69. DOI: 10.1186/s41983-022-00507-4. Go to original source...
    6. Chang HY, Jensen MP, Yang CC, Lai YH (2019). Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine. Health Qual Life Outcomes 17(1): 108. DOI: 10.1186/s12955-019-1169-y. Go to original source... Go to PubMed...
    7. Dermitzakis EV, Kouroudi A, Argyriou AA, Spingos KC, Bilias K, Vikelis M (2023). Results of a Web-Based Survey on 2105 Greek Migraine Patients - Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Medicina 59(1): 31. DOI: 10.3390/medicina59010031. Go to original source... Go to PubMed...
    8. Guilbeau JR, Lenahan CM (2015). Assessment, diagnosis, and management of headache. Women's Healthcare 3(3): 43-46.
    9. Hirata K, Komori M, Ueda K, Zagar AJ, Kim Y, Jaffe DH, et al. (2023). Outcomes and factors associated with insufficient effectiveness of acute treatments of migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study. Drugs Real World Outcomes 10(3): 415-428. DOI: 10.1007/s40801-023-00368-0. Go to original source... Go to PubMed...
    10. Kasem SM, Khodier RM, Fahim MK, Elsheikh MW (2023). Quality of life of patients with cervicogenic headache: A comparison with migraine patients without aura using MSQ v. 2.1 Questionnaire. Benha Medical Journal 40(annual conference issue), pp. 125-136.
    11. Kim BK, Chu MK, Yu SJ, Dell'Agnello G, Han JH, Cho SJ (2021). Burden of migraine and unmet needs from the patients' perspective: a survey across 11 specialized headache clinics in Korea. J Headache Pain 22(1): 45. DOI: 10.1186/s10194-021-01250-6. Go to original source... Go to PubMed...
    12. Klečka L (2019). Diferenciální diagnostika migrény. Neurol praxi 20(6): 444-450.
    13. Lipton RB, Cohen JM, Gandhi SK, Yang R, Yeung PP, Buse DC (2020). Effect of fremanezumab on quality of life and productivity in patients with chronic migraine. Neurology 95(7): e878-e888. DOI: 10.1212/WNL.0000000000010000. Go to original source... Go to PubMed...
    14. Nežádal T (2019). Chronická migréna. Neurol praxi 20(2): 115-120. Go to original source...
    15. Novotná I (2019). Bolesti hlavy, migréna, léčba a profylaxe. Neurol praxi 20(4): 302-306. DOI: 10.36290/neu.2019.132. Go to original source...
    16. Rendas-Baum R, Bloudek LM, Maglinte GA, Varon SF (2013). The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Qual Life Res 22(5): 1123-1133. DOI: 10.1007/s11136-012-0230-7. Go to original source... Go to PubMed...
    17. Rossi MF, Tumminello A, Marconi M, Gualano MR, Santoro PE, Malorni W, Moscato U (2022). Sex and gender differences in migraines: a narrative review. Neurol Sci 43(9): 5729-5734. DOI: 10.1007/s10072-022-06178-6. Go to original source... Go to PubMed...
    18. Shibata M, Nakamura T, Ozeki A, Ueda K, Nichols RM (2020). Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study. J Pain Res 13: 3531-3538. DOI: 10.2147/JPR.S287781. Go to original source... Go to PubMed...
    19. Speck RM, Shalhoub H, Ayer DW, Ford JH, Wyrwich KW, Bush EN (2019). Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome. J Patient Rep Outcomes 3(1): 39. DOI: 10.1186/s41687-019-0138-x. Go to original source... Go to PubMed...
    20. Taşkapilioğlu Ö, Karli N (2013). Assessment of quality of life in migraine. Noro Psikiyatr Ars 50(Suppl. 1): S60-S64. DOI: 10.4274/Npa.y7310. Go to original source... Go to PubMed...
    21. Vacca VM, Jr. (2019). Migraine in adults: A head start. Nursing 49(5): 23-29. DOI: 10.1097/01.NURSE.0000554607.72406.6e. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content